Monday, 31 August 2026European Markets

SOC FRANC CASINOS Stock Bearish Momentum With A 10% Slide So Far On Tuesday

Loading stream...

(vianews) - shares of soc franc casinos (cac 40: sfca.pa) dropped by a staggering 10.55% to €1.78 at 14:06 est on tuesday, after five consecutive sessions in a row of losses. cac 40 is falling 0.02% to €7,385.40, after five consecutive sessions in a row of gains. this seems, up until now, a somewhat bearish trend exchanging session today.

soc franc casinos's last close was €1.99, 5.24% under its 52-week high of €2.10.

about soc franc casinos

société française de casinos société anonyme operates casinos in france. the company is also involved in the hotel and restaurant activities. the company is based in paris, france.

earnings per share

as for profitability, soc franc casinos has a trailing twelve months eps of €0.33.

pe ratio

soc franc casinos has a trailing twelve months price to earnings ratio of 5.39. meaning, the purchaser of the share is investing €5.39 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.61%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, soc franc casinos's stock is considered to be overbought (>=80).

more news about soc franc casinos (sfca.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com